Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value

被引:5
|
作者
Alhudiri, Inas [1 ,2 ]
Nolan, Christopher [1 ]
Ellis, Ian [1 ]
Elzagheid, Adam [2 ]
Green, Andrew [1 ]
Chapman, Caroline [3 ]
机构
[1] Univ Nottingham, Biodiscovery Inst, Fac Med, Nottingham Breast Canc Res Ctr,Breast Pathol Res G, Nottingham, England
[2] Libyan Biotechnol Res Ctr, Genet Engn Dept, Tripoli, Libya
[3] Nottingham Univ Hosp NHS Trust, Eastern Bowel Canc Screening Hub, Nottingham, England
关键词
Breast cancer; Cathepsin D; Immunohistochemistry; Tissue microarray; Prognosis; GROWTH; ACTIVATION; INHIBITOR; ESTROGEN; SURVIVAL; INDEX; RNA;
D O I
10.1007/s10549-024-07293-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Cathepsin D is a proteolytic enzyme that is normally localized in the lysosomes and is involved in the malignant progression of breast cancer. There are conflicting results regarding Cathepsin D significance as prognostic and predictor marker in breast cancer. This study aimed to evaluate the expression and prognostic significance of Cathepsin D in early-stage breast cancer. Methods Expression of Cathepsin D was assessed by immunohistochemical staining of tissue microarrays, in a large well-characterized series of early-stage operable breast cancer (n = 954) from Nottingham Primary Breast Carcinoma Series between the period of 1988 and 1998 who underwent primary surgery. Correlation of Cathepsin D expression with clinicopathological parameters and prognosis was evaluated. Results Cathepsin D expression was positive in 71.2% (679/954) of breast cancer tumours. Positive expression of Cathepsin D was significantly associated with high histological grade (p = 0.007), pleomorphism (p = 0.002), poor Nottingham Prognostic Index (NPI) score (p < 0.002), recurrence (p = 0.005) and distant metastasis (p < 0.0001). Kaplan-Meier analysis showed that Cathepsin D expression was significantly associated with shorter breast cancer-specific survival (p = 0.001), higher risk of recurrence (p = 0.001) and distant metastasis (p < 0.0001). ER-positive tumours expressing Cathepsin D and treated with tamoxifen demonstrated a significantly higher risk of distant metastasis. Conclusion Cathepsin D expression significantly predicts poor prognosis in breast cancer and is associated with variables of poor prognosis and shorter outcome. The strong association of Cathepsin D with aggressive tumour characteristics and poor outcomes warrants further research of its potential as a therapeutic target The results also suggest a possible interaction between Cathepsin D and tamoxifen therapy in ER-positive breast cancer which needs further investigation to elucidate the underlying mechanisms.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 50 条
  • [1] Expression of cathepsin D in early-stage breast cancer and its prognostic and predictive value
    Alhudiri, Inas M.
    Nolan, Christopher C.
    Ellis, Ian O.
    Rakha, Emad A.
    Elzagheid, Adam
    Green, Andrew R.
    Chapman, Caroline J.
    CANCER RESEARCH, 2022, 82 (12)
  • [2] Expression of Lamin A/C in early-stage breast cancer and its prognostic value
    I. M. Alhudiri
    C. C. Nolan
    I. O. Ellis
    A. Elzagheid
    E. A. Rakha
    Andrew R. Green
    C. J. Chapman
    Breast Cancer Research and Treatment, 2019, 174 : 661 - 668
  • [3] Expression of Lamin A/C in early-stage breast cancer and its prognostic value
    Alhudiri, I. M.
    Nolan, C. C.
    Ellis, I. O.
    Elzagheid, A.
    Rakha, E. A.
    Green, Andrew R.
    Chapman, C. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (03) : 661 - 668
  • [4] Prognostic and predictive factors in early-stage breast cancer
    Cianfrocca, M
    Goldstein, LJ
    ONCOLOGIST, 2004, 9 (06): : 606 - 616
  • [5] Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer
    Andre, F.
    Nahta, R.
    Conforti, R.
    Boulet, T.
    Aziz, M.
    Yuan, L. X. H.
    Meslin, F.
    Spielmann, M.
    Tomasic, G.
    Pusztai, L.
    Hortobagyi, G. N.
    Michiels, S.
    Delaloge, S.
    Esteva, F. J.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 315 - 320
  • [6] REVIEW OF TRADITIONAL PROGNOSTIC AND PREDICTIVE MARKERS IN EARLY-STAGE BREAST CANCER
    Plun-Favreau, J.
    Luthman, S.
    Svedman, C.
    Mesterton, J.
    BREAST, 2013, 22 : S58 - S58
  • [7] Prognostic value of cathepsin D in breast cancer
    B R Westley
    F E B May
    British Journal of Cancer, 1999, 79 : 189 - 190
  • [8] Prognostic value of cathepsin D in breast cancer
    Stehle, G
    Wunder, A
    Hartung, G
    Sinn, H
    Heene, DL
    BRITISH JOURNAL OF CANCER, 1999, 81 (08) : 1427 - 1428
  • [9] Prognostic value of cathepsin D in breast cancer
    Westley, BR
    May, FEB
    BRITISH JOURNAL OF CANCER, 1999, 79 (02) : 189 - 190
  • [10] PROGNOSTIC INDICATORS FOR EARLY-STAGE BREAST-CARCINOMA .2. VALUE OF CATHEPSIN-D EXPRESSION, DETECTED BY IMMUNOCYTOCHEMISTRY - A MULTIPARAMETRIC STUDY
    BEVILACQUA, P
    BORACCHI, P
    GASPARINI, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 5 (03) : 559 - 564